Trevi Therapeutics, Inc.

Rachunek Zysków i Strat


Statystyki
Dywidendy
Rekomendacje
Wyceny
Wskaźniki
Analiza techniczna



Przychody TTM (mln): 0
EBIT TTM (mln): -45
index 0 1 2 3 4 5 6 7 8
Rok finansowy 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 0 0 0 0 0 0 0 0 0
Przychód Δ r/r 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%
Marża brutto -inf% 0.0% 0.0% -inf% -inf% -inf% -inf% -inf% 0.0%
EBIT (mln) -9 -8 -18 -27 -32 -32 -30 -34 -52
EBIT Δ r/r 0.0% -4.5% 123.5% 44.7% 21.9% -0.0% -7.9% 13.4% 51.9%
EBIT (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan
Koszty finansowe (mln) 0 3 0 0 0 1 1 0 -0
EBITDA (mln) -9 -8 -20 -27 -32 -33 -30 -34 -52
EBITDA(%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan
Podatek (mln) -0 -0 -0 -0 -0 -0 -0 -0 -0
Zysk Netto (mln) -11 -13 -21 -26 -33 -34 -29 -29 -48
Zysk netto Δ r/r 0.0% 16.0% 59.8% 26.8% 25.8% 3.6% -14.1% -0.3% 64.8%
Zysk netto (%) 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% nan
EPS -0.69 -1.43 -2.29 -2.22 -1.81 -1.49 -0.45 -0.29 -0.47
EPS (rozwodnione) -0.69 -1.43 -2.29 -2.22 -1.81 -1.49 -0.45 -0.29 -0.47
Ilośc akcji (mln) 16 9 9 12 18 23 65 99 101
Ważona ilośc akcji (mln) 16 9 9 12 18 23 65 99 101
Waluta USD USD USD USD USD USD USD USD USD